gsk, page-23

Hi Surges,

I note in the announcement that it does not say "Phase II clinical trials", but it does say "Phase II study agreement"
I believe you have misinterpreted the meaning of this announcement and I would argue that the trials you speak of are not required as they have already been conducted for the formulations when originally launched to market in their currently available form.
Thus your time lines I feel are excessive.
Glyn has also stated that they would not be pursuing this line of development of OBJ tech for these type of products given the regulatory requirements involved and the time it would take in the near future.